id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0575-0033,FDA,FDA-2013-D-0575,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Expedited Programs for Serious Conditions—Drugs and Biologics,Notice,60 Day Proposed Information Collection,2016-11-29T05:00:00Z,2016,11,2016-11-29T05:00:00Z,2017-01-31T04:59:59Z,2016-11-29T15:05:48Z,2016-28732,0,0,09000064823c5ea9